SEC Comment Letter for NovaBay Pharmaceuticals, Inc. (NBY) (CIK 0001389545) (SDEV) — Mar 4, 2011

NovaBay Pharmaceuticals, Inc. (NBY) (CIK 0001389545)
Date: March 4, 2011 · CIK: 0001389545 · Accession: 0000000000-11-013852

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-33678

Date

March 3, 2011

Author

Joel Parker

Form

UPLOAD

Company

NovaBay Pharmaceuticals, Inc. (NBY) (CIK 0001389545)

Letter

March 3, 2011 Ramin Najafi Chief Executive Officer and President NovaBay Pharmaceuticals, Inc. 5980 Horton Street, Suite 550 Emeryville, CA 94608

Re: NovaBay Pharmaceuticals, Inc. Form 10-K for the Fiscal Year Ended December 31, 2009 Filed March 30, 2010 File No. 001-33678

Dear Mr. Najafi:

We have completed our review of your f iling and do not have any further comments at this time. Sincerely,

Joel Parker A c c o u n t i n g B r a n c h C h i e f

Show Raw Text

March 3, 2011

Ramin Najafi
Chief Executive Officer and President
NovaBay Pharmaceuticals, Inc.
5980 Horton Street, Suite 550
Emeryville, CA 94608

Re: NovaBay Pharmaceuticals, Inc.
 Form 10-K for the Fiscal Year Ended December 31, 2009
Filed March 30, 2010
File No. 001-33678

Dear Mr. Najafi:

 We have completed our review of your f iling and do not have any further comments at
this time.
Sincerely,

Joel Parker
        A c c o u n t i n g  B r a n c h  C h i e f

SecProbe.io